A single-arm, phase II trial assessing the combination of AK105 and anlotinib in first-line treatment for persistent, recurrent, or metastatic cervical cancer

被引：0
|
作者：
Guo, Ruixia [1 ]
Qiu, Haifeng [1 ]
Wang, Qian [1 ]
Su, Ke [1 ]
Chang, Lei [1 ]
Cai, Mingbo [1 ]
Mao, Meng [1 ]
Bian, Aiping [1 ]
机构：
[1] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5530
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Apatinib in Combination with S-1 as First-Line Treatment in Patients with Advanced Metastatic Gastric Cancer: Results from an Open, Exploratory, Single-Arm, Phase II Trial
    Zhou, Na
    Zhang, Chuantao
    Liu, Dong
    Liu, Kewei
    Wang, Guanqun
    Zhu, Hua
    Zhang, Jianli
    Jiang, Man
    Liu, Ning
    Zhang, Xiaochun
    ONCOLOGIST, 2021, 26 (03): : E374 - E381
  • [22] Anlotinib plus Epirubicin Followed by Anlotinib Maintenance as First-line Treatment for Advanced Soft-tissue Sarcoma: An Open-label, Single-arm, Phase II Trial
    Wang, Zhi-ming
    Zhuang, Rong-yuan
    Guo, Xi
    Zhang, Chen-lu
    You, Yang
    Chen, Li-sha
    Liu, Wen-shuai
    Zhang, Yong
    Luo, Rong-kui
    Hou, Ying-yong
    Lu, Wei-qi
    Zhou, Yu-hong
    CLINICAL CANCER RESEARCH, 2022, 28 (24) : 5290 - 5296
  • [23] Anlotinib plus sintilimab in patients with recurrent advanced cervical cancer: A prospective, multicenter, single-arm, phase II clinical trial.
    Xu, Qin
    Chen, Chuanben
    Sun, Yang
    Huang, Zhangzhou
    Lin, Yibin
    Liu, Jing
    Li, Li
    Li, Zirong
    Pan, Junping
    Chen, Ying
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [24] MINOAS: A Single-arm Translational Phase II Trial of FOLFIRI Plus Aflibercept as First-line Therapy in Unresectable, Metastatic Colorectal Cancer
    Alexios Matikas
    John Souglakos
    Panagiotis Katsaounis
    Athanasios Kotsakis
    Panagiotis Kouroupakis
    Nikolaos Pantazopoulos
    Nikolaos Kentepozidis
    Adamantia Nikolaidi
    Ippokratis Messaritakis
    Ioanna Tzovara
    Dora Hatzidaki
    Efthymis Prinarakis
    Vassilis Georgoulias
    Targeted Oncology, 2019, 14 : 285 - 293
  • [25] MINOAS: A Single-arm Translational Phase II Trial of FOLFIRI Plus Aflibercept as First-line Therapy in Unresectable, Metastatic Colorectal Cancer
    Matikas, Alexios
    Souglakos, John
    Katsaounis, Panagiotis
    Kotsakis, Athanasios
    Kouroupakis, Panagiotis
    Pantazopoulos, Nikolaos
    Kentepozidis, Nikolaos
    Nikolaidi, Adamantia
    Messaritakis, Ippokratis
    Tzovara, Ioanna
    Hatzidaki, Dora
    Prinarakis, Efthymis
    Georgoulias, Vassilis
    TARGETED ONCOLOGY, 2019, 14 (03) : 285 - 293
  • [26] A single-arm phase II clinical trial of anlotinib combined with chemotherapy for the treatment of metastatic triple-negative breast cancer
    Huang, Jia-Yi
    Xie, Xiao-Feng
    Chen, Xue-Lian
    Zhang, Qiu-Yi
    Chen, Li-Ping
    Bai, Xue
    Lan, Xiao-Feng
    Song, Lin
    Guo, Jin-Feng
    Du, Cai-Wen
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [27] Pyrotinib in combination with docetaxel as first-line treatment for HER2-positive metastatic breast cancer (PANDORA): A single-arm, multicenter phase 2 trial
    Wang, Xiaojia
    Huang, Jian
    Zheng, Yabing
    Shao, Xiying
    Cao, Wenming
    Chen, Zhanhong
    Shi, Yanxia
    Cai, Li
    Chen, Wenyan
    Guo, Zhen
    Liu, Jian
    Shen, Peng
    Chen, Yiding
    Wang, Xian
    Li, Huiping
    Li, Man
    CANCER RESEARCH, 2022, 82 (04)
  • [28] Efficacy and Safety of Sintilimab Plus Anlotinib for PD-L1-Positive Recurrent or Metastatic Cervical Cancer: A Multicenter, Single-Arm, Prospective Phase II Trial
    Xu, Qin
    Wang, Junjie
    Sun, Yang
    Lin, Yibin
    Liu, Jing
    Zhuo, Yanhong
    Huang, Zhangzhou
    Huang, Songhua
    Chen, Ying
    Chen, Li
    Ke, Meifang
    Li, Li
    Li, Zirong
    Pan, Junping
    Song, Yanwen
    Liu, Rongqiang
    Chen, Chuanben
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : 1795 - +
  • [29] Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer
    Oaknin, Ana
    Ghamande, Sharad A.
    Kasamatsu, Yuka
    Gil-Martin, Marta
    Grau-Bejar, Juan Francisco
    Garcia-Duran, Carmen
    Sato, Masashi
    Siddiqui, Abdul
    Chaudhary, Surendra Pal
    Vugmeyster, Yulia
    Hasegawa, Kosei
    CLINICAL CANCER RESEARCH, 2024, 30 (05) : 975 - 983
  • [30] Radiotherapy combined with tislelizumab plus anlotinib as first-line treatment for hepatocellular carcinoma: A single arm, phase II clinical trial
    Wu, G.
    Liu, Y.
    Rao, M.
    Han, Y.
    He, K.
    Zhang, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S597 - S598
12345